Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc

							Bronstein, Gewirtz & Grossman, LLC Investigates
DaVita, Inc.
October 04, 2011 08:03 AM Eastern Daylight Time 

NEW YORK--(EON: Enhanced Online News)--Bronstein, Gewirtz & Grossman, LLC is investigating potential
claims on behalf of purchasers of the securities of DaVita, Inc. (“DaVita” or the “Company”) (NYSE: DVA),
concerning whether the company and certain of its officers and directors have violated federal securities laws.

DaVita disclosed in August a grand jury criminal probe by the U.S. Attorney in Denver. The Company said the
Colorado investigation appears to overlap with two other ongoing federal investigations into its business. DaVita is
charged with overbilling the Medicare system and overusing the drug Epogen, used to boost red blood cells for
those with kidney disease. The allegations against DaVita have been publicized for some time, but Citigroup analyst
Gary Taylor notes that recent rulings could start to pose significant legal risks. Under the False Claims Act – used in
the past against defense contractors that have overbilled the Pentagon—any damages the company is ordered to pay
could be automatically tripled. The Denver Post reports that the grand jury is also looking into allegations that the
Company entered into improper relationships with pharmaceutical companies and physicians. The stock has traded
between $59.61 and $89.76 in the last year and since DaVita reported its second quarter results on August 3, 2011,
the stock is down almost 20 percent.

If you are aware of any facts relating to this investigation, or purchased shares of DaVita, you can assist this
investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at
212-697-6484 or via email eitan@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing
address and telephone number.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive
pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in
class action security litigation, the firm’s expertise includes general corporate work, private securities offerings, and
securities arbitration.

Contacts
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman
212-697-6484
eitan@bgandg.com

Recent Stories from Bronstein, Gewirtz & Grossman, LLC
    l   Bronstein, Gewirtz & Grossman, LLC Investigates Imperial Holdings, Inc.
        September 28, 2011
        NEW YORK--(EON: Enhanced Online News)--Bronstein, Gewirtz & Grossman, LLC is investigating
        potential claims on behalf of purchasers of the securities of Imperial Holdings, Inc. (“Imperial Holdi... more »
    l   Bronstein, Gewirtz & Grossman, LLC Investigates Silvercorp Metals, Inc.
        September 14, 2011
        NEW YORK--(EON: Enhanced Online News)--Bronstein, Gewirtz & Grossman, LLC is investigating
        potential claims on behalf of purchasers of the securities of Silvercorp Metals, Inc. (“Silvercorp” or... more »
    l   Bronstein, Gewirtz & Grossman, LLC Investigates Pain Therapeutics, Inc.
        August 26, 2011
        NEW YORK--(EON: Enhanced Online News)--Bronstein, Gewirtz & Grossman, LLC is investigating
        potential claims on behalf of purchasers of the securities of Pain Therapeutics, Inc. (“Pain Therapeut... more »